Back to Resources

Scan4Safety: the evidence is in

Share on

The debate about whether Scan4Safety works is over. GS1 UK’s Scan4Safety evidence report, researched independently by The Public Service Consultants (The PSC), draws on interviews and data from 29 health organizations across the UK and Ireland, alongside an analysis of national National Health Service (NHS) cost data.

In his foreword, Lord Carter of Coles puts it plainly: “The question is no longer whether Scan4Safety works, but whether the NHS can move from committed adopters to consistent adoption across the system.”

Why this matters outside the UK: Scan4Safety is the UK’s program for scanning GS1 barcodes on patients, products and locations at the point of care. In the NHS, a “trust” is the organization that runs one or more hospitals, broadly comparable to a US health system. For US hospitals and health systems working to capture UDI at the point of care, the report offers a detailed look at what that work delivers at scale.

What the evidence shows

Patient safety comes first

The strongest evidence in the report sits at the point of care.

  • In one trust, point-of-care scanning flagged that a knee implant for the wrong side had been picked up, preventing a wrong-implant Never Event (the NHS term for a serious, wholly preventable incident).
  • One large acute care provider stopped 15 errors from becoming serious incidents in a single year.
  • One trust flagged more than 2,400 cases of an incorrect patient ID wristband being scanned during medication administration over two years.
  • Recall lists that once took at least eight days were produced in 40 minutes. Another trust produced its full list of patients affected by an implant recall within 17 minutes.

Time goes back to patients

  • One emergency department returned 168 hours a week of nursing time to patient care, the equivalent of four full-time nurses.
  • One trust saved more than 10,000 clinical hours a year across 12 specialties.

The financial case pays for itself

  • In every case the researchers examined, one-off savings covered the cost of implementation before any safety or productivity gains were counted.
  • Across 19 providers in the NHS Supply Chain inventory management program, £15.3M in savings had been captured by April 2026.
  • Trusts with higher adoption for medical devices show around 11 percent lower procedure-level costs for elective and same-day cases in national cost data. The authors describe this as an association rather than proof of cause, but a statistically significant one.

The gap

Adoption is uneven. Wales has had every health board and trust live since 2021, and Scotland is running a national program across its health boards. In England, GS1 UK’s 2026 maturity matrix puts average adoption at 66 percent, with a long tail of trusts yet to start.

The report models what would happen if the 32 trusts in England with the lowest adoption moved to inventory management and point-of-care scanning in operating rooms (theatres) and storerooms. The conservative estimate is 20 to 36 fewer serious incidents every year, £49M in recurrent productivity gains and £34M in one-off savings.

Five lessons from the trusts that got it right

  1. A mandate isn’t enough on its own. Scan4Safety has been mandated for years, yet adoption hasn’t kept pace with the evidence.
  2. Start with clinicians. Clinical leadership was the most consistent success factor in the research. Run Scan4Safety as a patient safety program with a board-level sponsor, not as a procurement project.
  3. Prepare before go-live. Reviewing and digitizing the product catalog, with the right GTIN against every product, is painstaking work. Everything else depends on it.
  4. Resource it properly. A dedicated, cross-functional team that stays with the program after go-live makes progress faster and more durable.
  5. Agree how benefits will be measured. Baselines from physical inventory counts, time-and-motion studies and incident data, set before implementation, make the impact provable.

Where Genesis fits

GS1 UK’s report is deliberately supplier-neutral, and it should be. But several of its strongest examples are trusts that have chosen Genesis.

The 15 errors stopped in a single year were at a Genesis trust. And Manchester University NHS Foundation Trust, where inventory management and the electronic health record (EHR) sync both ways every 60 seconds, runs that integration on Genesis. The credit belongs to the teams on the ground. What it shows is that this works at scale, in busy hospitals, every day.

Eleven of the 19 trusts in phase one of the NHS Supply Chain inventory management program have chosen Genesis. In the early months of that program, three of our trusts each identified between £127K and £162K of expired product in a single specialty: product that could otherwise have reached a patient.

Genesis is a Clinical Lifecycle Management Platform. From one scan at the point of care, it supports inventory management, GS1 traceability, recall management and patient-level costing. We worked closely with NHS England on a dedicated MDOR report, so the lot number, serial number and expiration date captured at the point of use go into Medical Device Outcome Registry submissions without being typed in by hand. Genesis integrates with the EHR, finance, procurement and catalog systems hospitals already run.

Standing still isn’t an option

The report ends on one line: “The risk now lies in standing still.”

We agree. Every year a trust waits is another year of recalls that take days when they could take minutes, of expired product sitting on shelves nobody can see, and of Never Events that a scan would have caught. The money matters too, but it follows the safety case, and the evidence shows it follows quickly.

Many NHS trusts are waiting for a national program to reach them. They don’t have to, and neither do US health systems waiting on a mandate. Much of the work that decides whether point-of-care scanning pays off can start now:

  • a clinical lead and a board sponsor, with Scan4Safety run as a patient safety program
  • a product catalog reviewed before go-live, with the right GTIN against every product
  • a dedicated team that stays with the program after go-live
  • a baseline agreed at the start, so the benefits can be proven afterward

None of those needs a contract signed to get started.

If you’re weighing what point-of-care scanning could look like in your hospital or health system, or what a sensible next step would be, talk to us. We’ll help you work it out.

Talk to the Genesis team

Read the GS1 report

Figures from GS1 UK, Accelerating Scan4Safety adoption for safer, smarter healthcare: The UK Scan4Safety evidence report (2026), independent research by The PSC, except where they relate to Genesis trusts. GS1 UK has not reviewed or endorsed this page.

See your item master through clean eyes. 

Request a free Data analysis. We measure non-file and non-contract spend, duplicates, missing HCPCS codes, contract overpayments, price parity, and FDA recalls. No commitment. Just the truth.

Looking up at tall modern skyscrapers against a clear blue sky.